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Abstract
An increasing interest in a healthy lifestyle raises questions about optimal body weight. Evidently, it should be clearly dis-
criminated between the standardised “normal” body weight and individually optimal weight. To this end, the basic principle 
of personalised medicine “one size does not fit all” has to be applied. Contextually, “normal” but e.g. borderline body mass 
index might be optimal for one person but apparently suboptimal for another one strongly depending on the individual 
genetic predisposition, geographic origin, cultural and nutritional habits and relevant lifestyle parameters—all included into 
comprehensive individual patient profile. Even if only slightly deviant, both overweight and underweight are acknowledged 
risk factors for a shifted metabolism which, if being not optimised, may strongly contribute to the development and pro-
gression of severe pathologies. Development of innovative screening programmes is essential to promote population health 
by application of health risks assessment, individualised patient profiling and multi-parametric analysis, further used for 
cost-effective targeted prevention and treatments tailored to the person. The following healthcare areas are considered to 
be potentially strongly benefiting from the above proposed measures: suboptimal health conditions, sports medicine, stress 
overload and associated complications, planned pregnancies, periodontal health and dentistry, sleep medicine, eye health 
and disorders, inflammatory disorders, healing and pain management, metabolic disorders, cardiovascular disease, cancers, 
psychiatric and neurologic disorders, stroke of known and unknown aetiology, improved individual and population outcomes 
under pandemic conditions such as COVID-19. In a long-term way, a significantly improved healthcare economy is one of 
benefits of the proposed paradigm shift from reactive to Predictive, Preventive and Personalised Medicine (PPPM/3PM). A 
tight collaboration between all stakeholders including scientific community, healthcare givers, patient organisations, policy-
makers and educators is essential for the smooth implementation of 3PM concepts in daily practice.
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Overweight parameters are as follows: for females, body 
mass index (BMI) 25–30 and for males, BMI 26–30.
Obesity parameters are as follows: class I—BMI 30–35; 
class II—BMI 35–40; class III—BMI > 40.
According to the WHO, in 2016, 50 million girls and 
74 million boys around the globe were registered as being 
obese. In Europe, problems of overweight are rapidly 
increasing in most of the member states demonstrating 
about 52% of the EU population aged > 18 years. More-
over, whereas in 2008, 25% of children aged 6–9 years 
were overweight or obese in Europe, in 2010, their num-
ber reached already 33%. Considering severe health risks 
linked to overweight in the population, the European Com-
mission has launched a European platform with more than 
300 initiatives to promote anti-overweight measures in the 
EU [1]. The aim is to combat severe physical and mental 
health adverse effects of overweight and obesity as both 
conditions are strongly associated with changes on the bio-
logical level, including increased inflammatory signalling, 
elevated levels of highly aggressive reactive oxygen spe-
cies (ROS) and altered endocrine stress hormone signal-
ling that synergistically may cause enormous burden of 
allostatic load lowering the resilience and coping ability 
of the body e.g. under chronic and traumatic stress.
Underweight
Underweight parameters are as follows: grade I: females, 
BMI < 19, males, BMI < 20; grade 2: BMI ≤ 17; grade 3: 
BMI ≤ 16.
In 2016, 75 million girls and 117 million boys globally 
were registered as moderately or severely underweight. 
Exemplified by French girls, against the year 1998, in 2006, 
the likelihood increased by 41% for them to be abnormally 
thin or even underweight.
Recent studies demonstrate that thinness is an over-
looked phenomenon in terms of causality, health risks and 
associated pathologies which are much less explored com-
pared to those associated with overweight and obesity [2, 
3]. Increased risks of syndromes and pathologies linked to 
both phenotypes, namely obese versus anorexic ones, are 
schematically presented in Fig. 1. Corresponding expertise is 
strongly multi-professional comprising cardiovascular, oph-
thalmologic, neurologic, psychologic, psychiatric, gynaeco-
logic, urologic, oncologic, otorhinolaryngologic and dental, 
amongst others [4].
Consequently, increasing interest in a healthy lifestyle 
raises questions about an optimal body weight. Evidently, 
a statistically normal weight does not mean individually 
optimal weight following the basic principle of person-
alised medicine “one size does not fit all”. Contextually, 
“normal” borderline BMI values such as 19–20 kg/m2 
might be optimal for one person but apparently subopti-
mal for another one strongly depending on the individual 
Fig. 1  Anorexic versus obese 
phenotype: The paradox of the 
similarity of health risks; the 
figure is adapted from [4]
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genetic predisposition, geographic origin, cultural and 
nutritional habits and other lifestyle parameters.
Within the standardised “normal” BMI range, which 
value is the personal optimum? In order to better under-
stand the challenge of answering the question, this is to 
exemplify the difference which corresponds to minimal 
versus maximal value of the “normal” range:
A. for the female height of 160 cm, according “normal” 
body weight may range between 47.5 and 64 kg with the 
difference of 16.5 kg (35%)
B. for the male height of 190 cm, according “normal” body 
weight may range between 66.5 and 90.5 kg with the 
difference of 24 kg (36%).
To this end, 35–36% of the body weight difference, if consid-
ered for the same person, would reflect significant shifts in the 
body composition with corresponding alterations in the tissue, 
cellular and molecular set-up such as muscles to the water and 
fat ratio, systems efficiency, free-radical production and activ-
ity of inflammatory signalling cascades, turnover and quality of 
metabolic processes and energy supply.
The current article highlights potential health risks 
associated specifically with the low body weight as well 
as intentional and unintentional weight loss to be consid-
ered for prediction of individual risks, targeted preven-
tion of health adverse effects and health-promoting rec-
ommendations tailored to the person in the framework of 
3P medicine.
Association of low and high BMI 
with overall mortality risks—generalised 
versus individualised risk presentation
In 2018, the association of BMI with overall and cause-spe-
cific mortality has been analysed within a population-based 
cohort of over 3.6 million adults in the UK [5]. In general, 
a “J”-shape association was demonstrated between BMI 
and overall mortality. However, the range of lowest risks 
differed between cause-specific mortality. To this end, the 
generalised lowest risks associated with cancers and cardio-
vascular diseases were demonstrated for the range 21–25 kg/
m2, whereas lowest risks for mental, behavioural, neurologi-
cal and accidental causes were associated with the range 
24–27 kg/m2. Further to this, disease-dependent mortality 
demonstrated highly individual shape of risks associated 
with the BMI:
– “J”-shape (higher risks at high BMI) was characteristic 
for cardiovascular diseases demonstrating risks associ-
ated with increasing BMI
– A mirrored “J” shape (higher risks at low BMI) was dem-
onstrated for neurological, mental and behavioural causes 
demonstrating an inverse association with increasing BMI
– Respiratory disorders demonstrated “U” risks associated 
with low and high BMI
– For mortality from self-harm, an inverse linear associa-
tion “\” was demonstrated: the risks were significantly 
decreased by increasing BMI.
Importantly, an association between BMI and mortality 
risks was stronger at younger ages.
Notably, increased mortality rates associated with a low 
BMI were demonstrated as being characteristic e.g. for neu-
rological dementia and mental/behavioural causes of death, 
whereas high BMI is strongly associated with hypertensive 
heart disease as the cause of death.
However, it is crucial to emphasise that BMI is a highly 
individual parameter to be considered in the context of 
many other factors as exemplified for prostate cancer (PCa) 
in Fig. 2.
To this end, being a multifactorial disease PCa results 
from a highly comprehensive interplay between exogenous 
and endogenous risk factors as clearly illustrated by the com-
plex association between the body mass index (BMI) and 
PCa-related mortality (Fig. 3). Whereas uterus cancer and 
related mortality are positively associated with overweight 
and obesity, for the PCa, this association is not that clear. 
Rather, in contrast, there is a mild decrease in mortality rates 
for obese PCa patients compared to those with normal and 
low BMI [6]. Contextually, individualised profiling is instru-
mental for data interpretation such as BMI.
Focus on adolescents: predisposition 
to intentional anorexic phenotype may 
appear early in life
Unmet needs in the healthcare of young populations in a 
long-term way cause epidemics of non-communicable dis-
orders. Currently, an unprecedented decrease in the average 
age of clinically manifested chronic disorders is observed 
being characteristic for the early twenty-first century. To this 
end, teenagers are more and more frequently diagnosed with 
type 2 diabetes mellitus type and depression; there is an 
increasing incidence of mood disorders and suicide in youth, 
alarming statistics of vascular stiffness in young populations, 
“young” strokes (> 50 years of age) with unknown aetiology, 
reproductive dysfunction, aggressive metastasising cancers 
in the 2nd and 3rd life-decades with particularly poor out-
comes, increasing prevalence of preventable eye disorders, 
inflammatory processes and allergic reactions and autoim-
munity, and respiratory disorders, amongst others [4].
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A paradox is that specifically in adolescents, the adverse 
health effects of suboptimal health conditions are revers-
ible in most cases. This unique capacity is, however, not 
adequately utilised by current concepts of healthcare: still, 
the clinical manifestation of the disease is the acknowl-
edged indicator for conventional medical services. How-
ever, the majority of non-communicable disorders carry 
a chronic character by progressing over a couple of years 
from a reversible suboptimal health condition to irrevers-
ible pathology with collateral complications. The timeframe 
between both conditions is the operational area for predictive 
diagnosis and identification of persons at risk by innovative 
screening programmes followed by the most cost-effective 
personalised treatment possible, namely primary prevention 
tailored to the person.
Specifically, in adolescents, physical and mental health 
linked to body shape plays the central role for major aspects 
such as successful career development, sexual life and long-
term partnering. Suboptimal health conditions make them 
vulnerable to associated pathologies early in life. For exam-
ple, a sedentary lifestyle leads to physical inactivity and 
weight gain with potentially cascading pathologies. To this 
end, German statistics demonstrate that from 100 teenagers 
aged 12–16 years, 11 are overweight and 9 obese. Similar 
numbers are recorded for many other industrial countries [4]. 
However, inadequate discussion on the matter gave rise to 
the opposed extreme situation which is not a less alarming 
trend: In Germany, about 50% of female teenagers and 25% 
of male teenagers with physiologically normal body shape 
do believe to be overweight undergoing unsupervised diet-
ing early in life. “Disordered eating” frequently leads to the 
clinical manifestation of eating and mental disorders as well 
as substance abuse in adolescence.
Amongst reported eating disorders, the absolute 
majority of cases are represented by anorexia nervosa 
and bulimia, wherefrom a great portion of bulimia cases 
originates from treated anorexia nervosa. The pubertal 
changes usually increase awareness of an individual body 
shape, when teenagers consider their bodies with enor-
mous self-criticism. To this end, if anybody expresses 
a negative opinion about their shape particularities, this 
might negatively impact individual attitude in a long-
term manner. Contextually, the most frequently discussed 
parameter is certainly the body weight and thinness as the 
symbol of beauty leading to the strong dieting intentional 
weight loss—the conceptual beginning of “disordered eat-
ing”. Frequently, the familiar environment shapes beauty 
symbol by thinness. Experienced psychiatrists report spe-
cific behavioural patterns associated with the following:
– dieting mothers: if the mother is permanently talking 
about or undergoes dieting frequently, her daughter(s) 
follow this behavioural pattern; even after the mother 
stops dieting, children often continues uncontrolled 
starvation until their condition is diagnosed as an “eat-
ing disorder”
– children of academics: for example, children of teach-
ers are particularly systematic and perfectionistic in 
dieting and developing anorexic conditions
– overprotected children: hyperactive parents strongly 
promote their initiatives focused on the children protec-
tion that significantly suppresses an adequate develop-
ment of own interests, activities and competencies by 
children, who simply follow the behavioural patterns 
of their parents
– “stiff” families which are highly conservative following 
traditions; any change is considered to be damaging the 
family and may lead to disordered behaviour of affected 
children including eating and mental disorders.
– “conflict-mitigating” behavioural pattern in the family, 
when parents are avoiding any opinion difference in the 
Fig. 2  A population-based 
cohort study by Bhaskaran et al. 
demonstrated the association 
between BMI and cause-specific 
mortality, exemplified here 
for never-smokers diagnosed 
with A prostate cancer versus 
B uterus cancer; the horizontal 
axis indicates BMI (kg/m2) 
and the vertical axis indicates 
hazard ratio (95% confidence 
interval); the image is adapted 
from [5]
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family as potentially “destabilising” that may lead to 
eating and mental disorders of teenagers.
Notably, particularly affected are usually teenagers with 
a meticulous personality and the tendency to perfectionism. 
Further to this, mood disorders such as depression go hand-
in-hand with eating disorders as detailed in [4].
Finally, adverse childhood experiences may play a role 
as a vulnerability factor for eating disorders. Childhood 
maltreatment (CM) comprises any kind of experience of 
physical, sexual or emotional abuse as well as physical and 
emotional neglect. According to the World Health Organiza-
tion, the worldwide prevalence is only estimated as precise 
numbers for any country are missing. However, the WHO 
provided data claiming that about 25% of all adults were 
exposed to physical abuse. For sexual abuse, the prevalence 
is about 20% for women and 8% for men, with about 13.5% 
of all children expected to be exposed to at least one experi-
ence of sexual abuse. Emotional abuse and physical abuse 
are the most present forms of CM and adverse childhood 
experiences (ACE) are not single events but have to be con-
sidered chronic and repetitive stressors and therefore limit 
the resilience and coping capability of affected subjects in 
a dose–response relationship. These findings are of epide-
miological, psychosocial and medical interest as ACE and 
CM are reported in literature to significantly contribute to 
the aetiology and manifestation of eating disorders on the 
one side and on the other side, ACE and CM are hardly 
considered in these clinical cohorts in the context of person-
alised diagnostic approach, treatment modalities and relapse 
prevention.
Abnormal stress reactions as a general risk 
of disease development, manifestation 
and progression
Flammer syndrome phenotype demonstrating characteris-
tic low body weight and abnormal reactions towards any 
kind of physical (e.g. cold provocation) and mental stress 
in affected individuals has been described [7, 8] as being 
strongly associated with an increased incidence of commu-
nicable and non-communicable disorders in this cohort [6, 
9–15]. The most prominent contributing factors and corre-
sponding pathomechanisms are summarised below.
Voice disturbances under stress overload 
and associated observations
A recently performed clinical study suggested voice distur-
bances as an indicator of an individual’s stress overload: the 
authors hypothesised that the voice perturbation in young 
(19–22 years old medicine students) and otherwise healthy 
individuals might be positively associated with vascular dys-
regulation and dry mouth syndrome[15]. Indeed, the study 
revealed voice perturbations under the stress overload as a 
potentially useful biomarker to identify individuals in sub-
optimal health conditions potentially vulnerable to related 
pathologies developed later on in life. To this end, low BMI 
(≤ 20) and symptoms of dry mouth syndrome and disturbed 
microcirculation were positively associated with voice 
perturbations under stress overload. Multivariate analysis 
applied to the same cohort, further, demonstrated a positive 
association between the following:
– perfectionistic altitude and sleep deficits (P < 0.01) as 
well as Sicca syndrome (P < 0.01)
– increased pain perception and impaired wound healing 
(P = 0.04)
– stroke cases in the family and frequent migraine with 
complications such as aura (P = 0.004) as well as evi-
dently shifted circadian rhythms (P = 0.04)—all well-
acknowledged risk factors in the proposed aetiology of 
the “young” stoke [12].
The authors recommended developing an automated 
analysis of voice records by application of artificial intel-
ligence with the potential to derive digital biomarkers. Fur-
ther to this, it has been concluded that predictive machine 
learning models might be useful for detecting a suboptimal 
health condition based on voice records followed by the 
detailed patient stratification utilising disease-specific cell-
free nucleic acids amongst other multi-omic technologies 
[16]. Application of the cost-effective targeted prevention as 
long as health damage remains reversible was recommended 
based on the individualised patient profiling [15].
Lasting vasospastic reactions
Under stress conditions, lasting vasospasm is caused by 
high blood plasma level of the vasoconstrictor endothelin-1 
(ET-1) strongly associated with systemic ischemic-hypoxic 
effects. In turn, ET-1 axes regulate a myriad of processes 
involved in a modulation of physical and mental well-being, 
female and male health, senses, pain, stress reactions, drug 
sensitivity and healing processes, amongst others. Imbal-
anced ET-1 overproduction modulates individual outcomes 
in the development and progression of communicable infec-
tions such as COVID-19 and non-communicable disorders 
such as metabolic impairments with cascading complica-
tions, ageing and related pathologies, cardiovascular dis-
eases, neurodegenerative pathologies, and aggressive malig-
nancies [17].
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Psycho‑immunology
Imbalanced stress reactions in a long-term manner may 
cause mood disorders such as depression which is strongly 
associated with compromised functionality and auto-regu-
lation of the immune system [18]. Chronic activation of the 
hypothalamic–pituitary–adrenal (HPA) axis in the stress 
response overload evidently impairs the immune response 
leading to the development and progression of related dis-
eases such as cardiovascular and cerebrovascular conditions, 
metabolic and autoimmune disorders and even cancers. 
Per evidence, stressors and depression are associated with 
the accumulation of somatic mutations and instability of 
genomic and mitochondrial DNA on the one hand and, on 
the other hand, with decreased cytotoxic T cell and natural-
killer-cell activities that affect the immune surveillance of 
tumours.
Sleep deprivation
Caused by abnormal stress reactions, sleep shortage and 
disturbances are per evidence the risk factors and facili-
tators of a broad spectrum of disorders, including mood 
disorders, stroke, chronic inflammation, immune defence 
insufficiency and cancer. The reciprocal interrelationship 
between the abnormal stress, sleep quality and individual 
outcomes became evident under extreme conditions such as 
the COVID-19 pandemic [19].
Mitochondrial dysfunction
Stress overload is a well-acknowledged risk factor of mito-
chondrial injury. In turn, mitochondriopathies play a key 
role in the aetiopathology of multifactorial diseases exhibit-
ing a “vicious circle” characteristic for multi-organ damage 
and failure in the long run. Uncontrolled release of reac-
tive oxygen species, diminished energy production in terms 
of adenosine triphosphate (ATP) resources and extensive 
damage to the life important biomolecules—synergisti-
cally present the generalised pathomechanisms of cascad-
ing pathologies frequently developed in a reciprocal man-
ner [20, 21]. Additionally, not only changes in the quality 
of mitochondrial bio-energetic output might contribute to 
the pathophysiology of stress-associated disorders, but also 
changes in the regulation of mitochondrial density inside 
the cells, further controlled by fission-and-fusion dynam-
ics as well as mitophagy in stressed cellular systems. As 
a result, the quantitative bio-energetic output of mitochon-
dria should also be normalised to the mitochondrial density 
inside cells of interest to correctly characterise the nature of 
the observation (mitochondrial dysfunction vs. impairment) 
when testing mitochondrial bioenergetics and the integrity 
of mitochondrial and genomic DNA in physical and mental 
health and disease conditions.
Systemic inflammation
Under imbalanced stress conditions, there are evident 
cumulative systemic effects leading to chronic inflamma-
tion including but not restricted to the lasting vasospas-
tic reactions with systemic ischemic-hypoxic effects and 
involvement of ET-1 and neuro-immune axes, mitochondrial 
impairments and increased infection susceptibility with poor 
outcomes such as caused by the cytokine storm reported for 
COVID-19-infected individuals [19, 22]. Chronic systemic 
inflammation is key risk factor in several non-communicable 
diseases such as cancers [23].
Impaired healing
Delayed and impaired healing is a multifactorial condition 
frequently associated with both abnormal body weight and 
stress overload [4, 24, 25]. In turn, impaired healing is 
indicative and predictive for a development and progres-
sion of many associated pathologies such as an aggressive 
metastatic disease, which is considered a “non-healing 
wound” [26]. Cellular responses to inflammation in both 
wound healing and metastasis are similar being tightly 
regulated by crosstalk with the surrounding microenvi-
ronment. Contextually, targeting canonical responses to 
inflammation is a novel strategy to prevent impaired heal-
ing and metastatic disease.
What is known about adverse effects 
of both intentional and unintentional 
weight loss within the “normal” BMI range?
Unintentional weight loss—prominent examples
Unintentional weight loss (UWL) comprises a diagnostic 
challenge for clinicians. Indeed, the main etiologic groups 
of UWL are represented by malignancies, non-malignant 
organic disorders and psychiatric disorders. To this end, 
unexplained UWL accounts for 11–28% of cases. Further 
to this, UWL is quite prevalent in the elderly and is con-
sidered a distinct clinical entity [27]. UWL is characterised 
as a more than 5% reduction in body weight within 6 to 
12 months [28]. Rapid and pronounced UWL indicates 
potentially underlying disease. For example, extensive 
cytokine release resulting from chronic or acute diseases 
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may induce anorexia nervosa development, stimulate lipoly-
sis, muscle protein breakdown and/or nitrogen loss [29].
Malnutrition BMI is a common measure of nutritional sta-
tus in adults [30]. There is a close association between UWL 
and malnutrition. Indeed, malnutrition can be defined as (a) 
BMI < 18.5 kg/m2 or (b) UWL > 10% of initial body weight 
irrespective of time or > 5% during last 3 months com-
bined with either BMI < 20 kg/m2 if < 70 years of age, or 
BMI < 22 kg/m2 if older than 70 years or fat-free mass index 
corrected for body size (FFMI) < 15 in women and < 17 kg/
m2 in men. Indeed, low BMI is not always associated with 
malnutrition while individuals with increasing BMI may 
have decreasing FFMI [31]. Malnutrition can result in vari-
ous complications such as delayed and impaired wound heal-
ing, an increase in postoperative morbidity and prolonged 
hospitalisation. To this end, early screening for patients 
at risk might lead to improved diagnostics and treatment 
approaches [32].
Elderly UWL is relatively prevalent in the elderly that is 
challenging. Indeed, 15–20% of adults aged ≥ 65 years 
demonstrate UWL with the prevalence higher in dwelling 
elders and nursing home residents [27]. Rapid UWL in the 
elderly indicates associated diseases and accelerate loss of 
muscles mass compared to physiological ageing [29]. UWL 
is strongly associated with increased morbidity and mortal-
ity rates in older populations [28]. Notably, malignancies, 
non-malignant organic disorders, non-malignant gastroin-
testinal disease, psychiatric and/or psychosocial disorders 
are the most common causes of the UWL in the elderly [27, 
28] with aetiology of the UWL similar to each other being 
also age-independent [27]. Further to this, Gaddey et al. 
reported on the non-malignant diseases as a more common 
cause of UWL in the older populations than malignancies. 
Social factors also contribute to the UWL in the elderly. 
Importantly, UWL in the elderly can result in a functional 
decline in the activities of living and increased in-hospital 
morbidity, risk of hip fractures in women, and overall mor-
tality. Moreover, cachexia described as a loss of muscle 
mass without loss of fat leads to infections, pressure ulcers 
and decreased response to treatments [28]. Moreover, low 
body weight in the elderly can result from decreased taste 
and smell as well as lack of appetite, due to reduced physi-
cal activity, drug interactions and dental complications 
[29]. Finally, low BMI has suggested a stronger predictor 
of premature death when compared with high BMI in older 
people [33].
Cancer UWL is an important indicator of malnutrition 
among surgical cancer patients; the awareness of UWL 
as an indicator of malnutrition needs to be evaluated dur-
ing cancer management, even if an individual BMI is 
within the normal range [32]. UWL commonly occurs to 
patients with locally advanced cervical cancer (LACC) 
receiving chemo-radiation that significantly affects indi-
vidual outcomes. Although being a relatively common 
phenomenon, the weight loss issue in the LACC patient 
cohort is under-estimated. Consequently, the focus on 
low body weight is essential to improve LACC outcomes 
[34]. Significant body weight reduction during radiation 
treatment is associated with poor survival, for example, 
for patients with nasopharyngeal cancer; this risk factor 
is more prominent in the initially low body weight group 
of patients [30]. Similarly, UWL is highly problematic 
also for patients with the gastrointestinal cancer nega-
tively impacting treatment efficacy and survival rates. 
Also, patients with upper gastrointestinal cancer and 
BMI < 20 kg/m2 have to be precisely evaluated for opti-
mal weight management interventions, since they exert 
the highest mortality rates. Experts recommend dedicat-
ing a lot of attention to optimise body weight manage-
ment in the overall cancer care and improved individual 
outcomes [35].
Intentional weight loss raises questions
Over several past decades, clinical intervention pro-
grammes for intentional weight loss have been devel-
oped. Doubtlessly, for obese sub-populations, those pro-
grammes are the real hope for returning to a normal life. 
However, how much help versus potential harm can occur 
to a spectrum of individuals intending weight loss, if 
stratified by age, gender, cultural traditions, geographic 
particularities, individual genetic predisposition, life-
style and professional occupation, amongst others? This 
issue is detailed in the subsequently presented sections. 
In general, body fat is suggested to be predicted from 
BMI considering both age and gender [36]. Per evidence, 
men lose more weight compared to women when uti-
lising similar weight loss interventions, potentially due 
to higher initial body weight [37]. Further to this, men 
and women respond differently to rapid weight loss: men 
tend to benefit more than women from the metabolic 
outcomes. Men demonstrate more pronounced reductions 
in metabolic syndrome Z‐score, C‐peptide, fat mass and 
heart rate, while women exert larger reductions in HDL 
cholesterol, hip circumference, bone mineral content 
(BMC), FFMI and pulse pressure. To this end, declines 
in HDL cholesterol, BMC and lean mass were demon-
strated to be necessarily health supportive in a long‐term 
way [38].
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Systemic effects and health risks associated 
with low body weight
The association between obesity and adverse health 
effects is widely recognised. In contrast, health risks 
associated with low body weight is much less explored. 
Certainly, being underweight increases mortality and 
reduces life expectancy [39]. Figure  3 highlights 
selected negative systemic effects of low BMI and 
underweight.
Fig. 3  Health risks potentially associated with low body weight; 
Explanatory notes: BMI classification: underweight—BMI < 18.5 kg/
m2; normal weight—BMI = 18.5 to 25 kg/m2; overweight—BMI ≥ 25 
to < 30 kg/m2; obese—BMI ≥ 30 to < 35 kg/m2; and severely obese—
BMI ≥ 35  kg/m2 [40, 41]. Selected suggested mechanisms behind 
increased risk of specific health complication associated with 
underweight include the following: abnormal  nutritional status, low 
body fat (e.g. anorexia athletica) or low muscle mass, muscular atro-
phy [42], cardiovascular abnormalities, valvular dysfunction, compro-
mised immunity [43]; cancer—particularly  poor outcomes  of some 
cancers, potentially  decreased tolerability/effectiveness of cancer 
treatment e.g. due to lower haemoglobin and albumin resulting from 
abnormal nutritional status, cachexia, impaired anti-tumour immu-
nity [44], loss of muscle fat mass, sarcopenia [45], increased risk 
of several  cancer  types and metastatic disease  [6, 46, 47]; impaired 
healing and increased post-surgical complications—abnormal nutri-
tional status, insufficient energy supply, shifted metabolic pathways 
and microbiome alterations [4, 24, 48],   potentially low preopera-
tive haemoglobin [49, 50]; reproductive dysfunction—disruption of 
hypothalamic-pituitary–gonadal axis leading to hypothalamic ano-
vulation [51], ovulatory dysfunction [52], negative effects on IVF 
parameters [53–55]; compromised immunity—abnormal nutritional 
status, lymphopenia [56]; respiratory infections including COVID-
19—malnutrition [57], coexisting chronic conditions [58], immuno-
suppression as a result of malnutrition [59]; eating disorders (ano-
rexia nervosa)—negative effects on overall and reproductive health 
[60]; neurological disorders such as young stroke [12] and abnormal 
pain sensitivity / perception [4, 7];  abnormal sleep patterns [7, 11, 
15] and  depression [61];  primary vascular dysregulation—abnor-
mal nutrition, low energy supply, Flammer syndrome, high Endothe-
lin-1 level in blood plasma, increased stress sensitivity, amongst oth-
ers [4, 9, 15, 17, 62]; Sicca syndrome with severe complications [11, 
13, 15].
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Cardiovascular diseases
The association between cardiovascular disease and over-
weight is mediated by “traditional” risk factors such as 
hypertension and diabetes [63]. Although, much less is 
known about cardiovascular risks in low body weight indi-
viduals and despite significantly lower prevalence of the 
“traditional” risk factors in this subpopulation, per evidence, 
underweight is associated with more severe and extensive 
coronary disease compared with the normal weight or even 
obesity [64]. Further to this, lean body mass has been dem-
onstrated as the predominant anthropometric risk factor of 
arterial fibrillation (AF). In contrast, any of the measures 
related to obesity have not been proved as an independent 
risk factor of the AF.
A cross-sectional study revealed a 19.7% greater risk 
of cardiovascular diseases of the underweight population 
compared with the normal-weight controls, specifically in 
the age category below 60. The association with the low 
body weight was found to be highly significant for the stroke 
risks [42]. To this end, young stroke of unclear aetiology 
has been hypothetically associated with the symptoms signs 
characteristic for individuals with the FS phenotype such 
as low body weight, abnormal stress reaction and vascular 
dysregulation [12].
Increased risk of cardiovascular diseases in the under-
weight sub-populations may be related to various factors, 
such as accelerated vascular ageing, sarcopenia, nutritional 
status, low body muscle mass and “metabolically obese 
underweight”, due to increased visceral fat (see the “Diag-
nostics of suboptimal low body weight” section) and meta-
bolic abnormalities [42]. Many studies associate excessive 
mortality with confounding by cachexia, also known as 
unintentional weight loss, fatigue and muscular atrophy that 
is related to chronic diseases. Notably, Bucholz et al. demon-
strated underweight as a risk factor of increased mortality in 
patients diagnosed with acute myocardial infarction (AMI) 
even independently of factors associated with cachexia such 
as comorbidities, frailty measures and laboratory markers 
of nutritional status. Higher mortality in the underweight 
patients’ cohort diagnosed with the AMI can be explained by 
an increased vulnerability to adverse health effects linked to 
additional weight loss, due to hospitalisation and increased 
infection susceptibility with complications [64]. Moreo-
ver, the Ohsaki study in Japan demonstrated a substantial 
association between underweight, haemorrhagic stroke 
and ischemic heart disease mortality, potentially due to the 
weakness of underweight patients (weak to survive). Further 
to this, being underweight was associated with an increased 
risk of cardiovascular abnormalities, valvular dysfunc-
tion, reduced ventricular mass, cardiac myofibril damage 
and compromised immunity [43]. Moreover, risks of total 
mortality, cardiovascular mortality and hospitalisation were 
the highest in the underweight chronic heart failure patients, 
while risks of cardiovascular mortality and hospitalisation 
were the lowest in overweight patients [65]. These results 
support the “obesity paradox” described as a better progno-
sis in overweight and mildly obese cardiovascular patients 
compared with lean cardiovascular-diseased counterparts 
[66–68]. Further to this, in the young population, vascular 
stiffness has been demonstrated to be a more frequent phe-
nomenon in otherwise healthy but low-weight individuals 
compared to their overweight counterparts (unpublished 
data of project-dedicated EPMA expert group; publication 
in preparation). The proposed mechanism includes abnormal 
stress reactions, chronically high levels of the endothelin-1 
in blood plasma and accelerated vascular ageing [17]. The 
EPMA expert group emphasises the need to differentiate 
between specific phenotypes in low-weight young popula-
tions; one of the stratification factors is connective tissue 
dysfunction. This dysfunction is clinically manifested by 
a whole set of external stigmas, amongst which the most 
frequent and accessible sign might be hypermobility of the 
joints further described in the “Reproductive dysfunction 
and pregnancy” section. The association between the con-
nective tissue dysfunction and specific organ alterations 
such as vegetative vascular dystonia, heart valve prolapses, 
cerebral artery malformations and ruptures and abnormally 
located left ventricular chords have been described [69]. 
Also, some forms of an angiopathy based on the systemic 
endothelin-1 overproduction and increased vascular stiff-
ness, which molecular mechanisms differ completely from 
usually observed vascular ageing, might be specific for this 
phenotype [65–68, 70]. Consequently, the EPMA expert 
group strongly recommends a detailed stratification of the 
affected individuals as being highly relevant for an accurate 
predictive diagnostics, targeted prevention and treatments 
tailored to the person.
Young stroke of unclear aetiology
Stroke is one of the most devastating disorders globally 
demonstrating 1-month case-fatality rates ranging from 
13 to 35%. The majority of cases appear in the advanced 
age population groups demonstrating well-acknowledged 
risk factors such as sedentary lifestyle, smoking, over-
weight, hypertension and abnormal sleep patterns. How-
ever, alarming statistics are provided by more recent 
studies demonstrating a persistently increasing stroke 
incidence in adolescents and young adults: “young” 
stroke (< 50 years of age) is a multifactorial disease fre-
quently described as being of unclear aetiology [12]. An 
example is provided below.
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Stroke mimics and young stroke—case report
A 24-year-old female was presented as a stroke patient. She 
exhibited right-sided hemiparesis—moderate at the upper 
extremity, mild in the lower extremity and with mild Broc-
ca’s aphasia. Multimodal CT was normal. A severe headache 
gradually developed, and hemiparesis and aphasia resolved. 
MRI ruled out stroke. The diagnosis was migraine with aura 
presented as a stroke mimic. In medical history, the patient 
suffered from headache in stressful situations and perimen-
strual headache, overactive bladder, stress urinary incon-
tinence, sleep disorder—falling asleep and insomnia, cold 
intolerance, excessive sweating, unpleasant perceived joint 
hypermobility, neck and low back pain and stress eating dis-
order accentuated during the university exam period. Clini-
cal findings are as follows: weight 45 kg, height 171 cm, 
BMI ˂16. Blood pressure in sitting position 102/60, asthenic 
figure, joint and spine hypermobility, acrocyanosis and acral 
hyperhidrosis, stress skin stains and faltering stress speech.
In summary, the patient was finally diagnosed with 
migraine with aura presented as a stroke-like episode (stroke 
mimics). Patient was evidently underweight and demon-
strated strongly pronounced symptoms and signs of Flammer 
syndrome such as low BMI, low blood pressure, disturbed 
microcirculation, dizziness, abnormal stress reactions, 
altered sense regulation and sleep patterns. Implemented 
treatment procedure comprised prophylactic migraine treat-
ment with cinnarizinum, and magnesium therapy. Personal-
ised approach and counselling were applied to maximise the 
treatment benefit. Partial reduction of symptoms occurred 
within follow-up of 22 months. She finished the university 
and started working as a trainee lawyer. The patient was 
included in the grant project of University Hospital Pilsen 
and Faculty of Medicine in Pilsen, Charles University, for 
the years 2021–2025 of detailed diagnostics, treatment and 
prevention of young stroke with potentially severe socio-
economic consequences.
Recommendations of the EPMA expert group
Less known risks specific for young populations and relevant 
for “young” stroke of unclear aetiology have to be explored 
such as low BMI, stress and ROS overload biomarkers and 
mitochondrial dysfunction, primary vascular dysregula-
tion, endothelin-1 overproduction, vascular stiffness, sys-
temic ischemic-hypoxic effects, low-grade inflammation and 
altered disease-specific molecular patterns in body fluids as 
well as their association with modifiable risk factors such 
as lifestyle, nutritional habits and supplements [15–17, 20, 
21, 71]. Corresponding risk-mitigating measures are rec-
ommended for targeted prevention including innovative 
screening programmes by application of specialised ques-
tionnaires and biomarker panels. Educational programmes 
is an essential pillar in the prevention to be adapted to the 
target audiences such as children, adolescents and young 
adults [12].
Pain of unclear aetiology—particularities 
of low body weight
The most prominent examples are headaches and migraines. 
Specifically, underweight individuals are considered to be 
belonging to the major group of patients with resistant and 
refractory migraine. To this end, lean patients have a specific 
muscle structural and functional patterns that participate in 
generating pain and provoke a specific muscle response 
patterns being more vulnerable to altered postural balance. 
Muscle and posture synergistically play a crucial role in par-
ticularities of the body composition relevant for increased 
pain perception and sensitivity that should be carefully con-
sidered for the individualised pain management in the lean 
patient cohort. Imaging data of muscle structure and func-
tion and overall posture is a rich source of biomarkers to be 
used for multi-level diagnostics, in order to stratify patients 
for treatments tailored to the person.
Myofascial trigger point (MTrP) is a pillar pathophysi-
ological unit in development of myofascial pain and pos-
tural imbalance. To this end, dry needling of MTrP under 
ultrasound (US) guidance is a powerful approach to treat 
myofascial pain [72]. Migraine aetiology and course are 
strongly associated with myofascial pain, body mechanics 
and posture. Further to this, overall muscle structure can 
be significantly altered in body weight loss. Additionally 
to mechanical stimuli, cumulative signalling of hypoxic 
MTrPs and inadequate stress reactions synergistically can 
provoke migraine relapse. This effect is more pronounced 
in a lean body phenotype, due to specific characteristics 
such as overall body set-up and systemic effects including 
but not restricted to vascular dysregulation with consequent 
development of ischemic-hypoxic niches as well as shifted 
regulation of senses [4, 73].
Systemic alterations at the molecular level may fur-
ther overlap between increased pain sensation/perception 
on the one hand and, on the other hand, specific reaction 
towards stress overload, inadequate temperature regulation 
and delayed and impaired healing processes with associ-
ated pathologies [9, 47]. To this end, more information is 
provided in the “Impaired wound healing” section below.
Impaired wound healing
Impaired healing is a multifactorial health complication 
affecting a big portion of populations with tremendous 
socio-economic impacts worldwide. In the USA, around 
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6.5 million patients are affected with a dedicated budget of 
25 billion US $ annually for treating chronic wounds [74]. 
Amongst the modifiable risk factors are unhealthy lifestyle, 
inappropriate nutritional habits, abnormal BMI and stress 
overload [24, 48].
Per evidence, underweight patients are at higher risk of 
mortality and poor outcome of general surgery compared 
to their overweight counterparts [49, 75]. Increased stress 
fracture rate and more severe course as well as delayed 
healing and return to sports activities were demonstrated 
for female runners with BMI ≤ 19 kg/m2 [76, 77]. Manrique 
et al. demonstrated a higher likelihood of surgical site infec-
tion and need for blood transfusion in the underweight total 
knee arthroplasty patients [49] potentially associated with 
impaired wound healing capabilities [49, 50]. Zusmanovich 
et al. demonstrated underweight as associated with increased 
length of a hospital stay [78]. Children’s Oncology Group 
reports on an increased risk of postoperative wound com-
plication in low BMI patients with localised osteosarcoma; 
the authors recommended early nutritional intervention to 
reduce wound complications [79].
Strong association between low body weight and impaired 
wound healing was observed in breast cancer patients under-
going breast reconstruction surgery. Low BMI phenotype 
particularities such as disturbed microcirculation and altered 
pain perception were further associated with aggressiveness 
of the disease and surgical complications after breast surgery 
(Treskova I et al., unpublished data of the project-dedicated 
EPMA expert group).
Cancers
A highly complex interrelation between individual body 
weight and cancer subtypes is a matter for a detailed evalu-
ation, since individually abnormal body weight is an evident 
risk factor of and a contributor to the cancer development, 
progression and quality of individual outcomes [45, 80, 
81]. Severe postoperative complications and poorer prog-
nosis were associated with low BMI in a large cohort of 
gastric cancer patients undergoing gastrectomy, due to the 
lower haemoglobin and albumin, cachexia and compromised 
immunity. To this end, gastric cancer patients with higher 
BMI undergoing gastrectomy demonstrate significantly bet-
ter survival rates compared to those with a BMI within the 
standard range [44]. Similarly, low BMI was demonstrated 
as an independent risk factor for increased mortality and 
co-incidence of cerebrovascular and pulmonary compli-
cations in resected lung cancer patients compared to their 
obese counterparts [82]. Underweight is suggested to be 
a predictor of poorer overall survival of colorectal cancer 
patients being potentially associated with poor performance 
status and decreased effectiveness of both the surgical and 
chemotherapeutic treatments [83]. Both obesity and under-
weight are related to a decreased survival in non-small-cell 
lung carcinoma (NSCLC) and small-cell lung carcinoma 
(SCLC) patients. A decrease in BMI from early adulthood 
to the time of diagnosis was associated with a 20 to 30% 
increase in poor survival of lung cancer patients [81].
Studies dedicated to prostate cancer–related mortality 
found out statistically significant risks associated with both 
high BMI (≥ 27.5 kg/m2) and low BMI (< 22.5 kg/m2) [84]. 
Further to this, data analysis performed towards 22 clinical 
trials revealed a positive association between overweight 
(BMI ≥ 25 kg/m2) and better overall survival amongst pros-
tate cancer [85]. To this end, patient stratification based on 
the individualised patient profiling was highly recommended 
by the authors as being essential for the correct interpreta-
tion of the data, prediction and prognosis for the prostate 
cancer risks as the multifactorial disease [6].
Chen et al. demonstrated the underweight to be charac-
teristic for breast cancer specifically in young Asian popula-
tions [45]. In consensus, underweight Korean premenopau-
sal women were associated with an increased risk of breast 
cancer incidence [46]. Low body weight was associated with 
aggressive metastatic breast cancer also in the European 
clinical studies focused on symptoms and signs potentially 
associated with “pre-metastatic niches” [9, 47, 86]. In terms 
of currently run population screening programmes, under-
weight women receive less attention than overweight and 
obese women in the USA. These deficits have been finally 
recognised: promoting breast and cervical cancer screening 
amongst this currently underserved population is strongly 
recommended to reduce future disparities [87].
Reproductive dysfunction and pregnancy
In 2019, young researchers Oksana Sergeeva and Vykto-
ria Kudryavtseva, Stavropol State Medical University, have 
been awarded in the category “Young professionals in 3P 
Medicine” by the European Association for Predictive, Pre-
ventive and Personalised Medicine for their discovery of the 
potential relevance of the vascular status of pregnant women 
with the FS phenotype for the foetal developmental particu-
larities [88]. The authors reported that otherwise healthy 
mothers with some symptoms of the FS phenotype such 
as frequently cold extremities and characteristic low body 
weight, compared with the control group, demonstrate sig-
nificantly increased vascular stiffness, altered gestational age 
(38.4 ± 0.81 vs. 39.5 ± 0.53) and trophic status of new-borns 
reflecting possible developmental particularities during the 
intrauterine period. To this end, in the target group, hypotro-
phy in new-borns was significantly more frequent compared 
to the controls (40% vs. 5.5%, respectively). Further to this, 
a significant difference was monitored for their peripheral 
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augmentation index AIx75 in the first trimester compared 
to the controls [89]. Prior to pregnancy, initial body mass 
index in the target and control groups was reported as 
being 20.9 ± 1.1 kg/m2 and 23.2 ± 1.5 kg/m2, respectively. 
For mothers in the target group, such a focal infection as 
chronic tonsillitis was diagnosed 2.3 times more frequently 
compared to controls. Finally, signs of joint hypermobility 
(thumb symptom, wrist symptom etc.) as markers of the 
systemic connective tissue dysfunction were observed 3.2 
times more frequently in pregnant and post-partum women 
of the target group compared to the controls, which in some 
cases was accompanied by changes in the valvular appara-
tus of the heart such as a mitral valve prolapse of varying 
severity (Sergeeva O, Evsevyeva M. et al., publication in 
preparation, 2021). More information about the association 
between connective tissue dysfunction and cardiovascular 
deficits characteristic for low body weight individuals is pre-
sented in the “Cardiovascular diseases” section.
There is a significant association between BMI and repro-
ductive health [90]. Infertility problems and unfavourable 
outcomes in pregnancy are reported in women with low 
weight [53]. Anovulatory infertility was associated with 
underweight. Chronic deficiency of energy, strenuous exer-
cise and stress overload can disrupt the hypothalamic-pitui-
tary–gonadal (HPG) axis leading to the hypothalamic anovu-
lation in young women [51]. Further to this, there is the risk 
of spontaneous abortion in underweight women. Non-clas-
sical congenital adrenal hyperplasia and ovarian dysfunction 
are prevalent in underweight women [90]. Although many 
women with non-classical congenital adrenal hyperplasia are 
generally fertile, there is a greater risk of subfertility, due to 
prevailing ovulatory dysfunction [52]. Low BMI was asso-
ciated with negative effects also in vitro fertilisation (IVF) 
parameters such as decreased probability of pregnancy and 
increased risk of miscarriage. Further to this, for the FET 
IVF, Tang et al. demonstrated underweight as being associ-
ated with adverse pregnancy outcomes, reduced implanta-
tion rates and reduced rates of clinical pregnancy and ongo-
ing pregnancy [91]. Low BMI is a risk factor of the male 
infertility, due to compromised semen quality [92].
Compromised immunity
BMI and nutrition status are both highly relevant for an 
adequate immune response. As an extreme case, the pri-
mary immunodeficiency diseases (PID) are characterised as 
a group of congenital disabilities of the immunity that result 
in susceptibility to infections, autoimmunity, lymphoprolif-
eration and atopy. A significantly higher prevalence of PID 
(adult and paediatric) is demonstrated in underweight with 
equal distribution of underweight patients in different PID 
diagnoses. Pre-existing poor nutritional status could modify 
the outcome of common variable immunodeficiency (CVID) 
predisposed individuals. Also, lymphopenia is observed in 
underweight children patients, while T cell lymphopenia is 
associated with CVID, lower immunoglobulin G levels and 
more autoimmune complications [56].
COVID‑19 and respiratory infections
There is a clear association between the individually physi-
ologic body weight and the ability of an organism to defend 
against infectious diseases including COVID-19 [57, 
93–95]. Obesity was associated with a more severe course 
of COVID-19. Further to this, Huang et al. recently dem-
onstrate a J-shaped curve indicating that both underweight 
and obese patients have higher mortality when compared 
with patients with the normal body weight [93]. These 
results are supported by other investigations indicating more 
severe viral respiratory infections and respiratory mortality 
in underweight and obese patients evaluating influenza and 
other respiratory viruses [93–95]. BMI exerts a complex 
relationship with another respiratory infection—commu-
nity-acquired pneumonia: underweight patients stay longer 
in the hospital. A prospective cohort study conducted on 
women from the Danish National Birth cohort showed an 
increased risk of community-acquired infectious diseases, 
including upper respiratory tract infections specifically for 
underweight individuals [96].
Diagnostics of suboptimal low body weight
As demonstrated in this position article, BMI is an impor-
tant but certainly not decisive parameter for evaluation of 
the most optimal body shape individually. Furthermore, 
the standardised “normal” BMI might be misleading—
the issue is well documented specifically for athletes and 
the elderly [97]. Individualised patient profiling utilising 
anthropometric data and medical and molecular imaging is 
instrumental to provide adequate diagnostics and person-
alised recommendations as presented earlier [4, 98, 99]. 
Medical imaging exemplified by evaluating subcutaneous 
(SAT) and visceral adipose tissue (VAT) measurements 
based on the ultrasound diagnostic approach is presented 
in Fig. 4. To this end, visceral versus subcutaneous types 
of the fat distribution demonstrate patterns specific for the 
patient stratification. Namely, subjects with visceral type of 
the fat distribution, rather than those with the subcutaneous 
type, may be significantly predisposed to an impaired flow-
mediated endothelium-dependent vasodilatation [100, 101]. 
Relevant for both overweight and underweight individuals, 
strong correlations between the specific type of fat distribu-
tion and corresponding gene expression patterns have been 
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demonstrated as a potential multi-level predictive diagnostic 
and prognostic tool [4, 102].
Specific microbiome profiles codetermine 
suboptimal health of underweight 
individuals
Microbiome profiles are highly relevant for the periodontal 
and otolaryngologic health, digestive and urogenital tracts, 
healthy skin and physiologic wound healing, and mood dis-
orders, amongst others [4, 6, 11, 13, 15, 103].
To this end, chronic inflammatory processes co-deter-
mined by shifted microbiome profiles frequently cause 
development and progression of severe pathologies such as 
cancers [23]. Further to this, xerostomia and vaginal dryness 
essentially associated with altered microbiome have been 
found to be more specific for young individuals demonstrat-
ing low body weight [11, 13].
Exemplified by an extreme condition under COVID-19 
pandemic, it has been demonstrated that periodontopathic 
microflora is secondarily implicated in bacterial superinfec-
tion, systemic inflammation and pneumonia development, in 
severe cases leading to sepsis and death [103].
In consensus, over 50% of deaths in COVID-19 infected 
patients exhibiting bacterial superinfections and severe dis-
ease course were reported [41]. Microbiome profiles shifting 
towards Prevotella, Staphylococcus and Fusobacterium dom-
inance representing periodontopathic bacteria were demon-
strated for patients with poor COVID-19 outcomes.
Intestinal microbial population has been proven to a large 
extent to influence human health and maintaining homeo-
stasis [104–107]. The setting of the gut microbiota depends 
on several factors such as host genetics, lifestyle, body 
activities, dietary habits, xenobiotics (e.g. antibiotics) and 
other drug intake as well as circadian rhythms [108–117]. 
In a number of studies, malnutrition and long-term dieting 
have been demonstrating as significantly influencing the gut 
microbiome and brain activity [118]. Remarkable alterations 
observed in animal models suggest that intestinal barrier 
dysfunction provoked by starvation may substantially con-
tribute to the pathophysiology of anorexia nervosa [119]. 
To this end, also other eating disorders have been associated 
with a disturbed gut barrier function [120]. Pro-inflamma-
tory cytokines levels significantly increased in acute ano-
rexia nervosa are get further normalised by comprehensive 
nutritional rehabilitation [121, 122].
The “lean” microbiome is to a great extent unexplored 
issue considered by a very few scientific papers such as 
dedicated to the impaired wound healing in lean individuals 
[24, 48] and abundantly in social media that clearly demon-
strates current discrepancy between pronounced interest in 
the population on the one hand but, on the other hand, very 
limited scientific efforts done to explore the topic.
Fig. 4  Ultrasound imaging as 
the diagnostic tool to discrimi-
nates between A abnormally 
low and B excessive versus 
C normal abdominal and 
visceral fat distribution and 
D SAT patterns in visceral fat 
redistribution; evident gender 
difference is well respected by 
gender-specific patterns of fat 
distribution, namely for males 
(B and D) and females (A and 
C). Notably, specific movement 
patterns at breathing further 
contribute to the correctness of 
the fat tissue measurement in 
abdominal cavity. The scanning 
was performed in the sagittal 
plane along the linea alba; the 
figure is adapted from [4]
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Nutritional mitigation of individual deficits
Nutritional aspects play a pivotal role in mitigating indi-
vidual deficits potentially diagnosed in individuals with 
intentional and unintentional low body weight. Prominent 
examples linked to most frequently observed symptoms such 
as deficient microcirculation reflected in cold extremities, 
headaches, sleep deprivation, healing quality and pain sever-
ity are provided below.
Deficient microcirculation reflected in cold 
extremities
There is a multifactorial causality of feeling cold and cold 
extremities of some individuals when other perceive tempera-
ture as comfortable; one of the reasons for that is a disturbed 
microcirculation frequently observed in vasospastic individ-
uals e.g. with Flammer syndrome phenotype including low 
BMI [9]. Increased endothelin-1 levels and stress sensitivity 
synergistically lead to abnormal vasoconstriction reflected in 
characteristic cold extremities—the phenomenon which may 
be accompanied by cascading pathologies such as glaucoma-
tous damage [7] and aggressive cancers [47, 86, 123].
Associated nutritional deficits are glucose, vitamin B, iron 
and magnesium amongst other dietary insufficiencies [4].
Increased levels of dietary magnesium may help to restore the 
balance between the blood levels of endothelin-1 as vasoconstric-
tor and NO as the vasodilator, therefore improving symptoms.
Headaches
Fasting and hypoglycaemia are common triggers of head-
ache and migraine in adults [124]. Affected individuals may 
be also very sensitive to one or more food components such 
as alcoholic drinks. The mechanism may be associated with 
the resulting dehydration and/or reaction towards ethanol, 
biogenic amines (including histamine, tyramine and pheny-
lethylamine), sulphides, phenolic flavonoids, amongst oth-
ers [124]. Further to this, micronutrient deficiencies such as 
vitamins B2 (riboflavin), B3 (niacin), B12 (cobalamin) and 
D and carnitine, α-lipoic acid and coenzyme Q10 have been 
associated with migraines; proposed mechanisms involve 
mitochondrial dysfunction, impaired antioxidant status 
and increased homocysteine levels [125]. Magnesium and 
nitrate supplementation is strongly recommended to restore 
vasodilatation and disturbed blood flow as the primary cause 
of headache and migraine in affected individuals [124, 126].
Sleep deprivation
Despite a growing body of literature demonstrating an 
evident relationship between the high-quality workload 
performance and sleep, there is still a lack of awareness 
about the key role of sleep patterns in optimising individual 
performance. Clear evidence has been provided for creat-
ing appropriate strategies to optimise sleep patterns in elite 
athletes including expanding total sleep duration and quality, 
improving sleep environment and/or identifying potential 
sleep disorders [127].
Anorexia nervosa patients evidently suffer from reduced 
total sleep time and sleep onset latency. Duration and sever-
ity of malnutrition significantly influence their sleep quality, 
and at least partial weight restoration results in a “deepen-
ing” of nocturnal sleep in anorexic patients [128, 129].
Dieting and nutrients play a pivotal role in regulation of 
the sleep duration and quality, which in turn is decisive for 
prevention of many non-communicable diseases as well as 
poor outcomes under pandemic conditions e.g. in COVID-
19 affected individuals [19]. To this end, high-carbohydrate 
diets and food containing tryptophan, melatonin and phyto-
nutrients (e.g. cherries) have been demonstrated to improve 
sleep outcomes. The proposed mechanisms include seroto-
nin and melatonin modulating pathways [130].
Healing quality and pain severity
Evident risks predisposing an individual to an impaired 
healing and increased pain severity—both tightly linked 
together—are preventable in many cases resulting from sub-
optimal lifestyle and dietary habits, which in turn have been 
associated with risks linked to the abnormal body weight and 
suboptimal weight loss. To this end, specifically low BMI 
has been identified as the risk factor for complications, for 
example, in tissue expander surgery [131]. In a supervised 
weight loss programme, pain severity has been demonstrated 
as the predictor of suboptimal weight loss outcomes [132]. 
Modifiable risks and corresponding mitigating measures can 
get more evident by individualised patient profiling, utilis-
ing dedicated questionnaires and detailed molecular imaging 
[4, 25].
Conclusions and expert recommendations 
in the framework of 3P medicine
Standardised “normal” versus individually optimal 
body weight
An increasing interest in a healthy lifestyle raises ques-
tions about optimal body weight. Evidently, it should be 
clearly discriminated between the standardised “normal” 
body weight and individually optimal weight. To this end, 
the basic principle of personalised medicine “one size does 
not fit all” has to be applied. Contextually, “normal” (but 
e.g. borderline) BMI might be optimal for one person but 
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apparently suboptimal for another one strongly depending 
on the individual genetic predisposition, geographic origin, 
cultural and nutritional habits and relevant lifestyle param-
eters—all included into comprehensive individual patient 
profile. Even if only slightly deviant, both overweight and 
underweight are acknowledged risk factors for a shifted 
metabolism which if being not optimised, in a long-term 
way, may strongly contribute to the development and pro-
gression of severe pathologies as highlighted above.
Currently applied weight loss programmes raise 
questions and concerns
To this end, a follow-up study involving 20,002 adults was 
performed in the USA to analyse the efficacy of receiving 
weight-related advice from healthcare professionals. This 
study did not find that weight-related advice from health-
care professionals demonstrated any positive impact on BMI 
loss. Rather, opposite effects have been monitored. Namely, 
patients who reported receiving weight-related advice 
achieved worse weight outcomes a year later, compared to 
unsupervised patients. In-depth analysis of the issue and 
corresponding research programmes are essential to eluci-
date impacts of the weight-related recommendations, opti-
mal lifestyle options and targeted prevention and treatment 
monitoring [133].
Occurrence of unexpected adverse effects following 
weight loss programmes may induce the accumulation of 
persistent organic pollutants into the bloodstream [134]. 
For example, intentional therapeutic loss of weight in dia-
betes type 2 patients potentially may not reach an expected 
decrease in risks to the disease on CVD, CVD mortality 
and all-cause mortality, due to methodological weaknesses 
[135]. Contextually, any effort in changing body weight has 
to be closely monitored by skilled healthcare professionals. 
The approach is comprehensive considering individualised 
patient profile and focused on the evidence-based benefits to 
the health condition of an individual in a long-term manner, 
therefore, following the principles of 3P medicine, namely 
application of predictive diagnostics, targeted prevention 
and treatment algorithms tailored to the person [136] and 
being safe, healthy, effective, nutritionally adequate and eco-
nomically affordable and adapted to healthy individual and 
persons at risk [137]. If not, weight-modifying programmes 
might be useless or even harmful.
Population health and innovative screening 
programmes
Development of innovative screening programmes is essen-
tial to promote population health by application of individu-
alised patient profiling, multi-parametric analysis leading to 
cost-effective targeted prevention e.g. for individuals in sub-
optimal health conditions with a reversible damage [16, 71].
Amongst others, following healthcare areas are consid-
ered to strongly benefit from the above proposed measures:
• Sports medicine
• Suboptimal health conditions
• Stress overload and associated complications
• Planned pregnancies
• Periodontal health and dentistry
• Sleep medicine
• Eye health and disorders
• Inflammatory disorders




• Psychiatric and neurologic disorders
• Stroke of known and unknown aetiology
• Improved individual and population outcomes under pan-
demic conditions such as COVID-19.
In a long-term way, a significantly improved health-
care economy is one of the clear benefits of the proposed 
paradigm shift from reactive medicine to 3PM; a tight col-
laboration between all stakeholders including scientific 
community, healthcare providers, patient organisations, 
policy-makers and educators is essential for the smooth 
implementation of the 3PM concepts [136, 138–141].
Further issues linked to big data management and medical 
ethics have to be carefully treated in the context of applica-
tion of artificial intelligence in medicine (below—see the 
“Application of artificial intelligence in medicine” section).
Application of artificial intelligence in medicine
The advent of artificial intelligence (AI) and machine learn-
ing in the life science domain has opened immense opportu-
nities to revolutionise the 3PMs. Leveraging the enormous 
amounts of biomedical data generated over the recent years 
(e.g. markers measured in biofluids, imaging modalities and 
various omics data), AI models can be built that learn from 
complex signals hidden in the data to make personalised 
predictions based on the biomarker signatures of individu-
als. Such models can, for example, predict clinical disease 
onset [11, 15–17, 71, 142], stratify patients into distinct 
sub-groups [10, 143–145], help understanding disease pro-
gression [71, 146] and aid as clinical decision support tools 
[147, 148].
AI methods are capable of integrating variables from var-
ious data modalities into large multivariate analyses which 
is especially important for highly complex, multifactorial 
diseases [149]. Here, the individual data types can lead to 
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a more detailed discrimination between disease phenotypes 
and thus can improve the sensitivity and specificity when 
conducting personalised prognoses compared to univariate 
models.
Developing robust, trustworthy AI approaches is a chal-
lenging task that requires a deep understanding of the appli-
cation domain, the available data and the technical approach 
[142, 146, 150]. This marks it a highly interdisciplinary 
endeavour where multiple experts need to collaborate. AI 
approaches catered towards the 3PMs depend on human data 
which is highly sensitive by nature. Therefore, a trade-off 
exists between ensuring data privacy through enforced regu-
lations and enabling/accelerating research through open data 
sharing. It needs to be ensured that the AI models do not 
disclose any information about individuals, or discriminate 
against certain groups of humans due to sampling biases in 
the training data.
In the medical domain, AI approaches remained largely 
a research area until now rather than making the transla-
tion into clinical practice [151]. The reason for this is mani-
fold: Before a proposed AI model can be applied in clinical 
practice, it needs to undergo several validation procedures 
to ensure accurate model performance and practical utility. 
First, the designed approach needs to be internally validated 
on the discovery dataset it was based upon, using appro-
priate internal validation procedures such as k-fold cross-
validation. Second, the learned model needs to be retrospec-
tively applied to external data (i.e. independent from the 
training data), where it should show approximately similar 
performance as on the original training data. Third, a pro-
spective study has to be conducted for the model (similar 
to prospective studies for drug candidates), where model 
predictions are evaluated against the observations made 
in reality. Finally, regulatory institutions have to carefully 
decide whether application of the model is practically fea-
sible, demonstrates a positive trade-off between risks and 
rewards and is considered ethical.
While there are ongoing challenges in the development 
and application of AI approaches in the biomedical context, 
there has been vast research progress over the last years. 
We believe that AI will stay a growing topic in the context 
of the 3PM over the upcoming years, potentially leading to 
an impactful paradigm shift with respect to how we think, 
pursue and enable the 3PM in research and clinical practice.
Sports medicine 
Olympic games 2020/2021 in Japan refreshed professional 
discussions about the anorexia athletica and associated 
health risks observed in elite athletes such as the female 
athlete triad (disordered eating, amenorrhea, and osteopo-
rosis) first described in 1992 by the American College of 
Sports Medicine and updated in 2007 including a spectrum 
of dysfunction related to energy availability, menstrual func-
tion, and bone mineral density. To this end, low energy sup-
ply, due to dietary restriction and increased expenditure, is 
considered to play a pivotal role in the triad development. 
Athletes involved in so-called “lean sports” which include 
but are not restricted to ballet, gymnastics and endurance 
running, are at highest risk. Still, there is an evident lack of 
effective screening programmes and management guidelines 
to mitigate health risks for the affected athletes. Effective 
risk assessment, targeted prevention and personalised inter-
vention are critical to treat anorexia athletica. Multi-profes-
sional caregiver groups must remain vigilant in education, 
recognition, and treatment of athletes at risk [152].
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